Correlation Between Shandong and Nanhua Bio
Specify exactly 2 symbols:
By analyzing existing cross correlation between Shandong Hi Speed RoadBridge and Nanhua Bio Medicine, you can compare the effects of market volatilities on Shandong and Nanhua Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shandong with a short position of Nanhua Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shandong and Nanhua Bio.
Diversification Opportunities for Shandong and Nanhua Bio
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Shandong and Nanhua is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Shandong Hi Speed RoadBridge and Nanhua Bio Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanhua Bio Medicine and Shandong is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shandong Hi Speed RoadBridge are associated (or correlated) with Nanhua Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanhua Bio Medicine has no effect on the direction of Shandong i.e., Shandong and Nanhua Bio go up and down completely randomly.
Pair Corralation between Shandong and Nanhua Bio
Assuming the 90 days trading horizon Shandong is expected to generate 1.37 times less return on investment than Nanhua Bio. But when comparing it to its historical volatility, Shandong Hi Speed RoadBridge is 1.44 times less risky than Nanhua Bio. It trades about 0.18 of its potential returns per unit of risk. Nanhua Bio Medicine is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 760.00 in Nanhua Bio Medicine on September 5, 2024 and sell it today you would earn a total of 308.00 from holding Nanhua Bio Medicine or generate 40.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Shandong Hi Speed RoadBridge vs. Nanhua Bio Medicine
Performance |
Timeline |
Shandong Hi Speed |
Nanhua Bio Medicine |
Shandong and Nanhua Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Shandong and Nanhua Bio
The main advantage of trading using opposite Shandong and Nanhua Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shandong position performs unexpectedly, Nanhua Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will offset losses from the drop in Nanhua Bio's long position.Shandong vs. Guangdong Jinma Entertainment | Shandong vs. Zhejiang Daily Media | Shandong vs. Duzhe Publishing Media | Shandong vs. JiShi Media Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |